Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (A59835) - R1 - Effective August 17, 2025

Date Posted: November 20,2025

This Billing and Coding Article has been revised under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Effective Date: August 17, 2025

Summary of Changes:

Under ICD-10 Codes that Support Medical Necessity Group 1: Codes added D75.839. This revision is effective 8/17/2025.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated Nov 19 , 2025